BLISSGVS

Bliss Gvs Pharma Share PriceBliss GVS Pharma

₹74.35
0.35 (0.47%)
As on 07 February, 2023 | 18:16 BSE: 506197 NSE: BLISSGVS

Bliss Gvs Pharma Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Bliss GVS Pharma

Start SIP

Bliss Gvs Pharma Share Price

  • Over 1 Month 4.13%
  • Over 3 Month -3.57%
  • Over 6 Month -5.65%
  • Over 1 Year -21.11%

Bliss Gvs Pharma Key Statistics

P/E Ratio 8.9
PEG Ratio 0
Market Cap Cr 772
Price to Book Ratio 0.9
EPS 8.7
Dividend 0.7
Relative Strength Index 51.3
Money Flow Index 87.33
MACD Signal 0.76
Average True Range 3.21

Bliss Gvs Pharma Investment Rating

  • Master Rating:
  • Bliss Gvs Pharma has an operating revenue of Rs. 733.87 Cr. on a trailing 12-month basis. An annual revenue growth of 30% is outstanding, Pre-tax margin of 7% is okay, ROE of 1% is fair but needs improvement. The company has a reasonable debt to equity of 3%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 200DMA and close to its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 41 which is a POOR score indicating inconsistency in earnings, a RS Rating of 39 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D+ which indicates heavy supply, Group Rank of 94 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Bliss GVS Pharma Financials
IndicatorDec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 169139147138
Operating Expenses Qtr Cr 135112128129
Operating Profit Qtr Cr 3327199
Depreciation Qtr Cr 4443
Interest Qtr Cr 1222
Tax Qtr Cr 111077
Net Profit Qtr Cr 2925259

Bliss Gvs Pharma Technicals

EMA & SMA

Current Price
₹74.35
0.35 (0.47%)
  • Bullish Moving Average
  • ___
  • 8
  • Bearish Moving Average
  • ___
  • 8
  • 20 Day
  • 74.26
  • 50 Day
  • 73.73
  • 100 Day
  • 74.48
  • 200 Day
  • 78.09
  • 20 Day
  • 73.78
  • 50 Day
  • 73.14
  • 100 Day
  • 74.19
  • 200 Day
  • 75.82

Bliss Gvs Pharma Resistance and Support

PIVOT
₹73.3
Resistance
First Resistance 75.7
Second Resistance 77.41
Third Resistance 79.8
RSI 51.3
MFI 87.33
MACD Single Line 0.76
MACD 0.68
Support
First Resistance 71.6
Second Resistance 69.2
Third Resistance 67.5

Bliss Gvs Pharma Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 271,613 12,507,779 46.05
Week 241,933 10,453,942 43.21
1 Month 550,155 12,620,556 22.94
6 Month 197,509 7,993,184 40.47

Bliss Gvs Pharma Result Highlights

Bliss GVS Pharma Synopsis

NSE-Medical-Generic Drugs

Bliss Gvs Pharma is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 636.36 Cr. and Equity Capital is Rs. 10.37 Cr. for the Year ended 31/03/2022. Bliss GVS Pharma Ltd. is a Public Limited Listed company incorporated on 11/12/1984 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH1984PLC034771 and registration number is 034771.
Market Cap 781
Sales 593
Shares in Float 6.86
No of funds 27
Yield 0.68
Book Value 0.9
U/D Vol ratio 1.8
LTDebt / Equity 3
Alpha -0.08
Beta 0.86

Bliss GVS Pharma

Owner NameDec-22Sep-22Jun-22Mar-22
Promoters 34.46%34.55%34.51%
Mutual Funds
Insurance Companies 6.63%6.64%6.65%
Foreign Portfolio Investors 16.53%16.68%17.17%
Individual Investors 30.73%30.57%30.15%
Others 11.65%11.56%11.52%

Bliss GVS Pharma Management

Name Designation
Mr. S R Vaidya Chairman & Ind.Director
Mr. Gagan Harsh Sharma Managing Director
Dr. Vibha Gagan Sharma Whole Time Director
Mrs. Shruti Vishal Rao Whole Time Director
Mr. Santosh Parab Independent Director
Mrs. Shilpa Bhatia Independent Director

Bliss Gvs Pharma Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Bliss Gvs Pharma Corporate Action

Date Purpose Remarks
2023-01-24 Quarterly Results
2022-11-07 Quarterly Results
2022-08-03 Quarterly Results
2022-04-30 Audited Results & Final Dividend
2022-01-29 Quarterly Results

Bliss GVS Pharma MF Shareholding

Name Amount(cr)
Motilal Oswal S&P BSE Healthcare ETF 6

Bliss GVS Pharma FAQs

What is Share Price of Bliss GVS Pharma ?

Bliss GVS Pharma share price is ₹74 As on 07 February, 2023 | 18:02

What is the Market Cap of Bliss GVS Pharma ?

The Market Cap of Bliss GVS Pharma is ₹772.4 Cr As on 07 February, 2023 | 18:02

What is the P/E ratio of Bliss GVS Pharma ?

The P/E ratio of Bliss GVS Pharma is 8.9 As on 07 February, 2023 | 18:02

What is the PB ratio of Bliss GVS Pharma ?

The PB ratio of Bliss GVS Pharma is 0.9 As on 07 February, 2023 | 18:02

Q2FY23